Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0302650 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Xiaoping Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Ferroptosis, Mice, Inbred C57BL, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bethune Charitable Foundation, National Natural Science Foundation of China, Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Introduction
Zhilong Huoxue Tongyu Capsule (ZL) is a Chinese medicine used for the treatment of cardio-cerebral diseases. However, the pharmacological mechanisms underlying its regulation of myocardial ischemia/reperfusion injury (MI/RI) remain unclear.
Purpose
This study aims to investigate the effects and mechanisms of ZL on MI/RI in mice. Materials and methods C57BL/6J mice were randomly assigned to four groups: Sham group, I/R group, ZL group, and ZLY group. The MI/RI mouse model was established by ligation of the left anterior descending coronary artery for 30 minutes, followed by reperfusion for 120 minutes to restore blood perfusion. Cardiac function was evaluated using cardiac ultrasound. Histopathological changes and myocardial infarction area were assessed using Hematoxylin and eosin (H&E) staining and triphenyltetrazolium chloride (TTC) staining. The changes in oxidative stress- and ferroptosis-related markers were detected. RT-qPCR, Western blot, and ELISA were conducted to further explore the mechanism of ZL in improving MI/RI.
Results
Our findings demonstrated that ZL exerted a protective effect against MI/RI by inhibiting ferroptosis, evidenced by the upregulation of antioxidant enzymes such as GSH and GPX4, coupled with the downregulation of ACSL4, a pro-ferroptosis factor. Furthermore, ZL positively impacted the PI3K/AKT/Nrf2 pathway by promoting ATPase activities and enhancing the relative protein expression of its components. Notably, the administration of a PI3K/AKT inhibitor reversed the antioxidant and anti-ferroptosis effects of ZL to some extent, suggesting a potential role for this pathway in mediating ZL’s protective effects.
Conclusions
ZL protects against MI/RI-induced ferroptosis by modulating the PI3K/AKT signaling pathway, leading to increased Nrf2 expression and activation of the HO-1/GPX4 pathway. These findings shed light on the potential therapeutic mechanisms of ZL in the context of cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- National Traditional Chinese Medicine Clinical Research Base and Department of Cardiovascular Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan, China.
ORCID-Profile: Gong Chen
Förderung
- Bethune Charitable Foundation
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
Zitieren
APA
Zhao, X., Yang, F., Wu, H., Fan, Z., Wei, G., Zou, Y., Xue, J., Liu, M., & Chen, G. (2024). Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis. PLOS ONE. https://doi.org/10.1371/journal.pone.0302650
Vancouver
Zhao X, Yang F, Wu H, Fan Z, Wei G, Zou Y, et al. Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis. PLOS ONE. 2024. doi:10.1371/journal.pone.0302650
BibTeX
@article{Zhao2024,
author = {Zhao, Xiaoping and Yang, Fang and Wu, Hao and Fan, Zhongcai and Wei, Gang and Zou, Yuan and Xue, Jinyi and Liu, Mengnan and Chen, Gong},
title = {Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0302650}
}
EUVIMED